General Information
Version
US Page 1 of 11
Revision date
2023-10-13
Product name
HTRF d2-NHS - 1 mg 65D2SABB
1.2.1 Relevant identified uses
Use of the substance or mixture for Laboratory Research use only ;
1.2.2. Uses advised against
Do not use for diagnostics, therapeutics or other clinical uses. ;
supplier name
CISBIO BIOASSAYS, company of Revvity Group
Emergency telephone
France - Numéro ORFILA (INRS) : + 33 (0)1 45 42 59 59
Icons in SDS
Company Information
company name
CISBIO BIOASSAYS, company of Revvity Group
e-mail address of the competent person responsible for the Safety Data Sheet
codolet.sds@revvity.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H318
Hazard statements
Code
Statements
H318
Causes serious eye damage.
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Classification in accordance with
Precautionary statements
HCS) Serious eye damage/eye irritation - Eye Dam. 1 - Eye Dam. 1 H318 P280|P305 + P351 + P338|P310 H318
2.2 Label elements
Labelling according to Hazard Communication Standard (HCS) (29 CFR 1910.1200(g))
Product definition
Designation / Trade name: HTRF d2-NHS - 1 mg 65D2SABB Substances contained in this product: Version US Page 2 of 11 Revision Date: 13/10/2023 Substance name CAS n° Index n° EC n° D2 NOCAS5
Hazard pictograms
GHS05-acid
Signal word
Danger Hazard and precautionary statements: Code Hazard statments H318 Causes serious eye damage. P280 Wear protective gloves/protective clothing/eye protection/face protection. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P310 Immediately call a POISON CENTER/doctor/…
2.3 Other hazards
The mixture does not contain substances classified as ‘Substances of Very High Concern' (SVHC) >= 0.1% published by the European CHemicals Agency (ECHA) under article 57 of REACH. The mixture satisfies neither the PBT nor the vPvB criteria for mixtures in accordance with annexe XIII of the REACH regulations EC
Potential health effects
Version US Page 3 of 11 Revision Date: 13/10/2023